Shanghai - Delayed Quote CNY

DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS)

Compare
14.15
+0.28
+(2.02%)
At close: January 27 at 3:00:03 PM GMT+8
All numbers in thousands
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
24,123,300.76
20,841,243.24
17,335,681.73
15,445,044.68
Total Liabilities Net Minority Interest
16,190,216.09
13,977,090.81
11,399,804.36
10,080,950.87
Total Equity Gross Minority Interest
7,933,084.68
6,864,152.43
5,935,877.38
5,364,093.81
Total Capitalization
8,461,533.88
7,673,324.40
6,730,725.85
6,386,630.39
Common Stock Equity
6,823,853.09
6,211,882.36
5,478,577.16
5,179,347.01
Capital Lease Obligations
3,070,008.37
2,790,076.01
2,951,928.40
2,572,538.44
Net Tangible Assets
1,920,206.74
3,147,572.19
2,742,339.23
3,307,043.78
Working Capital
-655,267.43
962,028.42
692,261.01
1,971,223.96
Invested Capital
9,194,748.86
8,370,632.97
6,896,163.57
6,577,489.71
Tangible Book Value
1,920,206.74
3,147,572.19
2,742,339.23
3,307,043.78
Total Debt
6,496,551.34
5,931,133.68
5,275,103.02
4,721,109.12
Share Issued
1,138,902.10
1,138,942.15
1,138,963.13
1,138,097.35
Ordinary Shares Number
1,138,902.10
1,138,942.15
1,138,963.13
1,138,097.35
12/31/2020 - 7/31/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade